CD8A and neoplasm: Importantly, this reduction in M2‐like macrophages was accompanied by a marked increase in CD8+ T cell infiltration, as demonstrated in single‐cell RNA‐seq analysis, flow cytometry, and IF staining (Figure 5), suggesting that Fulvestrant relieves macrophage‐mediated suppression and facilitates cytotoxic T cell entry into the tumor microenvironment.